Weekly renewables M&A round-up (May 23-27)
May 27, 2022 17:26 CEST(SeeNews) - Jan 18, 2013 - US contract research company for the pharmaceutical and biotech industries A5 Laboratories Inc (OTCBB:AFLB) said yesterday it intends to switch its operations and step on the alternative energy generation.
In a bid to boost shareholder value, he company will concentrate on the development of renewable energy generation products and services, its newly-appointed chairman and chief executive Frank Neukomm said. At a later point in the near future, the company will change its name to Hydra Fuel Cell Corp, it said.
As part of the plan, A5 Laboratories has reshuffled its management team and appointed its former chairman and CEO Robert Farr as chief operating officer (COO) and president.
Weekly renewables M&A round-up (May 23-27)
May 27, 2022 17:26 CESTDuke Energy equips Hawaii university with solar and storage
May 27, 2022 17:17 CESTUS stays atop EY renewables attractiveness index, Spain heads PPA chart
May 27, 2022 16:32 CESTSavannah Energy to develop up to 500 MW of renewables in Chad
May 27, 2022 16:08 CESTCelsia building 260 MW of solar farms in Colombia
May 27, 2022 15:51 CESTAgrana, RWA equip Austrian fruit juice concentrate plant with solar modules
May 27, 2022 15:36 CEST